Donna Reece
0009-0002-9686-4323
Publication & Citation Trends
Publications
0 total
Survival and Renal Recovery in Newly Diagnosed Multiple Myeloma Patients Presenting With Dialysis‐Requiring Severe Renal Impairment
Cited by 0
Semantic Scholar
Operationalising Patient Selection for Outpatient Transplant in Multiple Myeloma: Subjective Versus Objective Measures
Cited by 0
Semantic Scholar
Mel200 or BuMel conditioning in myeloma: is there a winner?
Cited by 0
Semantic Scholar
A Single‐Center Study on Frontline Treatment for Multiple Myeloma Patients With 1q Abnormalities
Cited by 0
Semantic Scholar
Desensitization of Immunomodulating Agent–Related Hypersensitivity Reactions as a Means to Provide Therapeutic Options in the Management of Plasma Cell Disorders (DeHyperPCD)
Cited by 0
Semantic Scholar
Final Results of the Canadian Myeloma Research Group Trial of Cybord Induction, Double-Alkylator Conditioning with High-Dose Intravenous Busulfan + Melphalan, ASCT and Continuous Lenalidomide Maintenance for Patients with Newly Diagnosed Multiple Myeloma (CMRG-001)
Cited by 1
Semantic Scholar
Handgrip Strength - Finetuning an Objective Measure of Frailty in Transplant-Eligible Patients with Multiple Myeloma
Cited by 0
Semantic Scholar
Outcomes of Relapsed/Refractory Multiple Myeloma Patients Receiving Sequential Therapies after Exposure to T-Cell Redirected or BCMA-Targeted Novel Immunotherapies
Cited by 1
Semantic Scholar
Research Topics
Multiple Myeloma Research and Treatments
(462)
Protein Degradation and Inhibitors
(211)
Cancer Treatment and Pharmacology
(115)
Peptidase Inhibition and Analysis
(99)
Chronic Lymphocytic Leukemia Research
(52)
Affiliations
Boston University
Brigham and Women's Hospital
University of British Columbia Hospital
University of Colorado Hospital
BC Cancer Agency